Racemic mixtures and single stereoisomers: Industrial concerns and issues in drug development
- 1 January 1991
- Vol. 3 (2), 94-98
- https://doi.org/10.1002/chir.530030203
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Enantiomer specific pharmacokineticsPharmacology & Therapeutics, 1990
- Enantioselective Aspects of Drug Action and Disposition: Therapeutic PitfallsJournal of Pharmaceutical Sciences, 1989
- RACEMATES OR ENANTIOMERS: REGULATORY APPROACHESClinical and Experimental Pharmacology and Physiology, 1989
- The FDA perspective on the development of stereoisomersChirality, 1989
- Stereoselectivity: An Issue of Significant Importance in Clinical PharmacologyPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1988
- Pharmacokinetic Analysis of the Enantiomeric Inversion of Chiral Nonsteroidal Antiinflammatory DrugsPharmaceutical Research, 1988
- Pharmacodynamic and pharmacokinetic differences between drug enantiomers in humans: An overviewClinical Pharmacology & Therapeutics, 1986
- Importance of Drug Enantiomers in Clinical PharmacologyDrugs, 1985
- Stereochemistry, a basis for sophisticated nonsense in pharmacokinetics and clinical pharmacologyEuropean Journal of Clinical Pharmacology, 1984